Trial: 201612148

A Multicenter, Pivotal Phase 3 Study of Iomab-B Prior to Allogeneic Hematopoietic Cell Transplantation versus Conventional Care in Older Subjects with Active, Relapsed or Refractory Acute Myeloid Leukemia



Principal Investigator

Abboud, Camille

Disease Site

Acute Myeloid Leukemia (AML); Myeloid and Monocytic Leukemia

Learn more about this study at: